Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66298-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- CD19 antibody
- Antibody type
- Monoclonal
- Description
- CD19 antibody (Cat. #66298-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C10A1
- Vial size
- 20ul, 150ul
Submitted references CD4 T cell-secreted IFN-γ in Sjögren's syndrome induces salivary gland epithelial cell ferroptosis.
Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.
Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.
Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages.
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
The impact of tobacco exposure on tumor microenvironment and prognosis in lung adenocarcinoma by integrative analysis of multi-omics data.
Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors.
Zhou J, Pathak JL, Cao T, Chen B, Wei W, Hu S, Mao T, Wu X, Watanabe N, Li X, Li J
Biochimica et biophysica acta. Molecular basis of disease 2024 Apr;1870(4):167121
Biochimica et biophysica acta. Molecular basis of disease 2024 Apr;1870(4):167121
Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.
Zhou J, Zhou R, Zhu Y, Deng S, Muhuitijiang B, Li C, Shi X, Zhang L, Tan W
Journal of experimental & clinical cancer research : CR 2024 Apr 2;43(1):101
Journal of experimental & clinical cancer research : CR 2024 Apr 2;43(1):101
Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.
Zhang X, Zhao P, Ma M, Wu H, Liu R, Liu Z, Cai Z, Liu M, Xie F, Ma X
Frontiers in medicine 2023;10:1168977
Frontiers in medicine 2023;10:1168977
Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
Song T, He N, Hao Z, Yang Y
Journal of cellular physiology 2023 Jun;238(6):1308-1323
Journal of cellular physiology 2023 Jun;238(6):1308-1323
The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages.
Chen L, Li Y, Zeng S, Duan S, Huang Z, Liang Y
In vitro cellular & developmental biology. Animal 2022 May;58(5):408-418
In vitro cellular & developmental biology. Animal 2022 May;58(5):408-418
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
Huang R, Zeng Z, Yan P, Yin H, Zhu X, Hu P, Zhuang J, Li J, Li S, Song D, Meng T, Huang Z
Cancer cell international 2021 Jan 4;21(1):3
Cancer cell international 2021 Jan 4;21(1):3
The impact of tobacco exposure on tumor microenvironment and prognosis in lung adenocarcinoma by integrative analysis of multi-omics data.
Lu X, Ma L, Yin X, Ji H, Qian Y, Zhong S, Yan A, Zhang Y
International immunopharmacology 2021 Dec;101(Pt B):108253
International immunopharmacology 2021 Dec;101(Pt B):108253
Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors.
Tang X, Li Y, Ma J, Wang X, Zhao W, Hossain MA, Yang Y
Cancer letters 2020 Sep 1;487:1-9
Cancer letters 2020 Sep 1;487:1-9
No comments: Submit comment
No validations: Submit validation data